Ikarian Capital’s Science 37 Holdings, Inc. Common Stock SNCE Stock Holding History

Ikarian Capital’s Portfolio SNCE Stock Details SNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-25,623	Closed	-$5.2M	–	308
2021 Q1	$5.2M	Buy	25,623 +373	+1%	+$81.1K	0.17%	115
2020 Q4	$5.36M	Buy	+25,250	New	+$5.25M	0.24%	89

Other funds holding SNCE

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

K2 Principal Fund Toronto, Ontario, Canada $1.43B AUM 29.56% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Monashee Investment Management Boston, Massachusetts $184M AUM 197.43% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Ikarian Capital's SNCE Position: Q2 2021 in Review

Ikarian Capital sold out of Science 37 Holdings, Inc. Common Stock (SNCE) in Q2 2021, closing a stake of 25,623 shares — an estimated $5.2M sold.

Ikarian Capital first reported a position in SNCE in Q4 2020 and held it in 2 quarters. The position peaked at $5.36M in Q4 2020. 30 funds tracked by Wall St. Rank hold SNCE as of Q2 2021.

Ikarian Capital reported no remaining Science 37 Holdings, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
Ikarian Capital sold 25,623 Science 37 Holdings, Inc. Common Stock shares in Q2 2021, an estimated $5.2M.
Ikarian Capital first reported a position in Science 37 Holdings, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
Ikarian Capital's Science 37 Holdings, Inc. Common Stock position peaked at $5.36M in Q4 2020.
30 funds tracked by Wall St. Rank held Science 37 Holdings, Inc. Common Stock as of Q2 2021.

Based on Ikarian Capital's 13F filing for Q2 2021, filed 16 Aug 2021.